Emergence of a clinical Salmonella enterica serovar 1,4,[5], 12: i:-isolate, ST3606, in China with susceptibility decrease to ceftazidime-avibactam carrying a novel blaCTX-M-261 variant and a blaNDM-5

Jie Wei,Shimei Shen,Qinghuan Zhang,Jinping Lu,Shenglan Mao,Chunhong Zou,Hua Zhou,YeLin Wei,Xingyi Ou,Jinyu Huang,Deqiang Wang,Xiaobin Li,Qun Wan,Baoju Shan,Zhenlin Zhang
DOI: https://doi.org/10.1007/s10096-024-04765-3
2024-02-24
European Journal of Clinical Microbiology & Infectious Diseases
Abstract:The detection rate of Salmonella enterica serovar 1,4,[5], 12: i: - (S. 1,4,[5], 12: i: -) has increased as the most common serotype globally. A S . 1,4,[5], 12: i: - strain named ST3606 (sequence type 34), isolated from a fecal specimen of a child with acute diarrhea hospitalized in a tertiary hospital in China, was firstly reported to be resistant to carbapenem and ceftazidime-avibactam. The aim of this study was to characterize the whole-genome sequence of S. 1,4,[5], 12: i: - isolate, ST3606, and explore its antibiotic resistance genes and their genetic environments.
infectious diseases,microbiology
What problem does this paper attempt to address?